United Spirits Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 28, 2025, 7:31 pm

Competitors of United Spirits Ltd

All Competitor Stocks of United Spirits Ltd

Quarterly Result

Last Updated: August 22, 2025, 10:24 am

Below is a detailed analysis of the quarterly data for United Spirits Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 3,021.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,031.00 Cr. (Mar 2025) to 3,021.00 Cr., marking a decrease of 10.00 Cr..
• For Expenses, as of Jun 2025, the value is 2,383.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2,572.00 Cr. (Mar 2025) to 2,383.00 Cr., marking a decrease of 189.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 638.00 Cr.. The value appears strong and on an upward trend. It has increased from 459.00 Cr. (Mar 2025) to 638.00 Cr., marking an increase of 179.00 Cr..
• For OPM %, as of Jun 2025, the value is 21.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Mar 2025) to 21.00%, marking an increase of 6.00%.
• For Other Income, as of Jun 2025, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 175.00 Cr. (Mar 2025) to 58.00 Cr., marking a decrease of 117.00 Cr..
• For Interest, as of Jun 2025, the value is 49.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 22.00 Cr. (Mar 2025) to 49.00 Cr., marking an increase of 27.00 Cr..
• For Depreciation, as of Jun 2025, the value is 76.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 70.00 Cr. (Mar 2025) to 76.00 Cr., marking an increase of 6.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 571.00 Cr.. The value appears strong and on an upward trend. It has increased from 542.00 Cr. (Mar 2025) to 571.00 Cr., marking an increase of 29.00 Cr..
• For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 22.00% (Mar 2025) to 27.00%, marking an increase of 5.00%.
• For Net Profit, as of Jun 2025, the value is 417.00 Cr.. The value appears to be declining and may need further review. It has decreased from 421.00 Cr. (Mar 2025) to 417.00 Cr., marking a decrease of 4.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 5.73. The value appears to be declining and may need further review. It has decreased from 5.79 (Mar 2025) to 5.73, marking a decrease of 0.06.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 10:24 am

Growth

Last Updated: September 5, 2025, 1:50 pm

Balance Sheet

Last Updated: August 22, 2025, 10:24 am

Below is a detailed analysis of the balance sheet data for United Spirits Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 145.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 145.00 Cr..
• For Reserves, as of Mar 2025, the value is 7,959.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,976.00 Cr. (Mar 2024) to 7,959.00 Cr., marking an increase of 983.00 Cr..
• For Borrowings, as of Mar 2025, the value is 480.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 265.00 Cr. (Mar 2024) to 480.00 Cr., marking an increase of 215.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 4,592.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,790.00 Cr. (Mar 2024) to 4,592.00 Cr., marking an increase of 802.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 13,176.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11,176.00 Cr. (Mar 2024) to 13,176.00 Cr., marking an increase of 2,000.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,712.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,560.00 Cr. (Mar 2024) to 1,712.00 Cr., marking an increase of 152.00 Cr..
• For CWIP, as of Mar 2025, the value is 72.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Mar 2024) to 72.00 Cr., marking an increase of 35.00 Cr..
• For Investments, as of Mar 2025, the value is 923.00 Cr.. The value appears strong and on an upward trend. It has increased from 645.00 Cr. (Mar 2024) to 923.00 Cr., marking an increase of 278.00 Cr..
• For Other Assets, as of Mar 2025, the value is 10,469.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,934.00 Cr. (Mar 2024) to 10,469.00 Cr., marking an increase of 1,535.00 Cr..
• For Total Assets, as of Mar 2025, the value is 13,176.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,176.00 Cr. (Mar 2024) to 13,176.00 Cr., marking an increase of 2,000.00 Cr..

Notably, the Reserves (7,959.00 Cr.) exceed the Borrowings (480.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for United Spirits Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 22.28. This value is within the healthy range. It has increased from 19.83 (Mar 24) to 22.28, marking an increase of 2.45.
• For Diluted EPS (Rs.), as of Mar 25, the value is 22.28. This value is within the healthy range. It has increased from 19.83 (Mar 24) to 22.28, marking an increase of 2.45.
• For Cash EPS (Rs.), as of Mar 25, the value is 25.82. This value is within the healthy range. It has increased from 23.23 (Mar 24) to 25.82, marking an increase of 2.59.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 111.78. It has increased from 98.22 (Mar 24) to 111.78, marking an increase of 13.56.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 111.78. It has increased from 98.22 (Mar 24) to 111.78, marking an increase of 13.56.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 166.47. It has increased from 156.15 (Mar 24) to 166.47, marking an increase of 10.32.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 35.57. This value is within the healthy range. It has increased from 30.70 (Mar 24) to 35.57, marking an increase of 4.87.
• For PBIT / Share (Rs.), as of Mar 25, the value is 31.67. This value is within the healthy range. It has increased from 26.91 (Mar 24) to 31.67, marking an increase of 4.76.
• For PBT / Share (Rs.), as of Mar 25, the value is 29.54. This value is within the healthy range. It has increased from 25.63 (Mar 24) to 29.54, marking an increase of 3.91.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 21.92. This value is within the healthy range. It has increased from 19.43 (Mar 24) to 21.92, marking an increase of 2.49.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 21.82. This value is within the healthy range. It has increased from 19.42 (Mar 24) to 21.82, marking an increase of 2.40.
• For PBDIT Margin (%), as of Mar 25, the value is 21.36. This value is within the healthy range. It has increased from 19.66 (Mar 24) to 21.36, marking an increase of 1.70.
• For PBIT Margin (%), as of Mar 25, the value is 19.02. This value is within the healthy range. It has increased from 17.23 (Mar 24) to 19.02, marking an increase of 1.79.
• For PBT Margin (%), as of Mar 25, the value is 17.74. This value is within the healthy range. It has increased from 16.41 (Mar 24) to 17.74, marking an increase of 1.33.
• For Net Profit Margin (%), as of Mar 25, the value is 13.16. This value exceeds the healthy maximum of 10. It has increased from 12.44 (Mar 24) to 13.16, marking an increase of 0.72.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 13.10. This value is within the healthy range. It has increased from 12.43 (Mar 24) to 13.10, marking an increase of 0.67.
• For Return on Networth / Equity (%), as of Mar 25, the value is 19.52. This value is within the healthy range. It has decreased from 19.77 (Mar 24) to 19.52, marking a decrease of 0.25.
• For Return on Capital Employeed (%), as of Mar 25, the value is 26.92. This value is within the healthy range. It has increased from 26.55 (Mar 24) to 26.92, marking an increase of 0.37.
• For Return On Assets (%), as of Mar 25, the value is 11.94. This value is within the healthy range. It has decreased from 12.51 (Mar 24) to 11.94, marking a decrease of 0.57.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has decreased from 1.08 (Mar 24) to 0.98, marking a decrease of 0.10.
• For Current Ratio (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has increased from 1.89 (Mar 24) to 1.95, marking an increase of 0.06.
• For Quick Ratio (X), as of Mar 25, the value is 1.46. This value is within the healthy range. It has increased from 1.36 (Mar 24) to 1.46, marking an increase of 0.10.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.53. This value is within the healthy range. It has increased from 5.27 (Mar 24) to 5.53, marking an increase of 0.26.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 40.39. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 40.39, marking an increase of 40.39.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 34.26. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 34.26, marking an increase of 34.26.
• For Earning Retention Ratio (%), as of Mar 25, the value is 59.61. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 59.61, marking an increase of 59.61.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 65.74. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 65.74, marking an increase of 65.74.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 28.98. This value is within the healthy range. It has decreased from 29.29 (Mar 24) to 28.98, marking a decrease of 0.31.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 19.58. This value is within the healthy range. It has decreased from 19.76 (Mar 24) to 19.58, marking a decrease of 0.18.
• For Enterprise Value (Cr.), as of Mar 25, the value is 99,593.25. It has increased from 80,992.75 (Mar 24) to 99,593.25, marking an increase of 18,600.50.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 8.25. This value exceeds the healthy maximum of 3. It has increased from 7.15 (Mar 24) to 8.25, marking an increase of 1.10.
• For EV / EBITDA (X), as of Mar 25, the value is 38.62. This value exceeds the healthy maximum of 15. It has increased from 36.38 (Mar 24) to 38.62, marking an increase of 2.24.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.42. This value exceeds the healthy maximum of 3. It has increased from 7.26 (Mar 24) to 8.42, marking an increase of 1.16.
• For Retention Ratios (%), as of Mar 25, the value is 59.60. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 59.60, marking an increase of 59.60.
• For Price / BV (X), as of Mar 25, the value is 12.54. This value exceeds the healthy maximum of 3. It has increased from 11.55 (Mar 24) to 12.54, marking an increase of 0.99.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.42. This value exceeds the healthy maximum of 3. It has increased from 7.26 (Mar 24) to 8.42, marking an increase of 1.16.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness